Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 316 | 2,010 | 1,752 | 2,076 | 1,532 |
| Cost of Goods | 18 | 53 | 10 | 59 | 6 |
| Gross Profit | 298 | 1,957 | 1,742 | 2,017 | 1,526 |
| Operating Expenses | 8,849 | 11,117 | 10,284 | 9,501 | 8,606 |
| Operating Income | -8,533 | -9,107 | -8,532 | -7,425 | -7,074 |
| Interest Expense | 114 | 125 | 132 | 128 | 139 |
| Other Income | -81 | 2,945 | -751 | -3,997 | 1,603 |
| Pre-tax Income | -8,728 | -6,287 | -9,415 | -11,550 | -5,610 |
| Income Tax | N/A | N/A | -70 | -902 | -451 |
| Net Income Continuous | -8,728 | -6,287 | -9,345 | -10,648 | -5,159 |
| Net Income | $-8,728 | $-6,287 | $-9,345 | $-10,648 | $-5,159 |
| EPS Basic Total Ops | -0.18 | -0.13 | -0.20 | -0.24 | -0.12 |
| EPS Basic Continuous Ops | -0.18 | -0.13 | -0.20 | -0.24 | -0.12 |
| EPS Diluted Total Ops | -0.18 | -0.13 | -0.20 | -0.24 | -0.12 |
| EPS Diluted Continuous Ops | -0.18 | -0.13 | -0.20 | -0.24 | -0.12 |
| EPS Diluted Before Non-Recurring Items | -0.18 | -0.17 | N/A | N/A | N/A |
| EBITDA(a) | $-7,586 | $-8,156 | $-7,593 | $-6,450 | $-6,100 |